Total lymphoid irradiation uses radiation to limit the production of
white blood cells (lymphocytes). These cells help the
body's immune system destroy foreign cells and fight infection. The treatment
was first developed to treat
Hodgkin's lymphoma, a form of cancer.
In theory, total lymphoid irradiation may help prevent progression of
multiple sclerosis (MS) by limiting the production of lymphocytes and thus limiting the activity of
the immune system. The results of studies done so far have failed to show any
Total lymphoid irradiation remains an experimental treatment for MS.
The treatment may be toxic and potentially dangerous and typically is not
How this information was developed to help you make better health decisions.